The once-daily pill offers new oral cardiovascular risk-reduction option for plan members with diabetes Heart disease is still the second leading cause of death in Canada, and most Canadians have at least one risk factor now a oncedaily GLP1 pill adds a new option for adults with type 2 diabetes and cardiovascular risk
5A, B), suggesting a hemin-mediated suppression of TSS pathway
As we age we become more nutritionally deficient, leading to possible cellular changes that can damage your DNA damage that can lead to premature aging, chronic disease, cancer, and early death
Stress induces the release of corticotropin-releasing hormone (CRH) from paraventricular nucleus of hypothalamus and mast cells
We're here to provide the support and advanced therapies you need to truly thrive
DHEA use to improve likelihood of IVF/ICSI success in patients with diminished ovarian reserve: A systematic review and meta-analysis